Anti-EGFRvIII antibody [EPR28380-83]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Anti-EGFRvIII antibody [EPR28380-83] (ab313646) is a rabbit monoclonal antibody suitable for WB, IP, Flow Cyt, IHC-P, ICC/IF and reacts with Transfected cell lysate - Human, Human, Transfected cell line - Human, Transfected cell line samples.
Enhanced IHC validation data - Download the data
- validated for confirmed specificity of EGFRvIII vs. EGFR
- detailed IHC expression profiling in normal and clinically relevant cancer FFPE TMAs- glioblastoma
- EGFRvIII/EGFR duplex staining in glioblastoma
- singleplex/duplex protocols for BOND RX™ and Ventana DISCOVERY ULTRA
Over 50 publications
Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Immunohistochemical analysis of formalin fixed paraffin-embedded human glioblastoma and placenta tissues labelling EGFRvIII with ab313646 and EGFR with ab52894 at a concentration of 2.5 µg/ml and 0.5 µg/ml.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins. Primary antibodies were incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin.
Tissue obtained from the Human Research Tissue Bank, supported by the NHR Cambridge Biomedical Research Centre.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized 293T (human embryonic kidney epithelial cell) labelling EGFRvIII with ab313646 at 1/500 dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green). Cells were counterstained with anti-Myc tag Mouse mab [9E10] (Alexa Fluor® 594) at 1/100 dilution (Red). The Nuclear counterstain is DAPI (Blue).
Confocal image showing cytoplasmic and membrane staining in 293T cells overexpressing human EGFRvIII. No staining in 293T cells overexpressing human wild-type EGFR. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 µg/mL) dilution.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Chromogenic duplex (2-plex) immunohistochemical staining of formalin fixed paraffin-embedded human glioblastoma tissue performed on a Roche Ventana Discovery Ultra instrument.
Heat mediated antigen retrieval was performed with CC1 solution for 64 min at 95°C. Two rounds of primary antibody incubation were performed each for 16 min at 37°C. anti-EGFRvIII (ab313646; 1st primary antibody; 3 µg/ml) and anti-EGFR (ab52894; 2nd primary antibody; 0.5 µg/ml). Antibody denaturation was conducted after the first round of staining using Ultra CC2 solution for 8 min at 100°C to avoid cross reactivity.
Signal was developed with anti-rabbit HQ followed by anti-HQ HRP coupled with purple (Discovery purple kit (RUO) #760-229) and teal (Discovery teal kit (RUO) #760-247) chromogens and counterstained with haematoxylin II.
Tissue obtained from the Human Research Tissue Bank, supported by the NHR Cambridge Biomedical Research Centre.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Flow cytometric analysis of 293T (human embryonic kidney epithelial cell) transfected with a human EGFRvIII expression vector containing a His-Myc tag (top left, bottom left); human wild-type EGFR expression vector containing a His-Myc tag (top right); empty vector containing a His-Myc tag (bottom right). Cells were fixed with 2% paraformaldehyde and permeabilised with 0.1% Tween-20. Cell labelling of EGFRvIII with ab313646 at 1/500 dilution. A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) was used at 1/5000 dilution. Isotype control - Rabbit monoclonal IgG (ab172730). No cross-reactivity with human wild-type EGFR.
Cells were surface stained with primary antibody. Fixed with 2% PFA for 10 min followed by intracellularly staining with anti-Myc tag conjugated to Alexa Fluor® 647.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Immunohistochemical analysis of paraffin-embedded 293T (human embryonic kidney epithelial cell) transfected with (A) human EGFRvIII expression vector containing a Myc-His tag; (B) human wild-type EGFR expression vector containing a Myc-His tag; (C) empty vector containing a His tag. Whole cell pellet labelling of EGFRvIII with ab313646 at 1/100 (5.09 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining on 293T overexpressing human EGFRvIII (image A). No staining on 293T overexpressing human wild-type EGFR (image B) or the empty vector control (image C). The section was incubated with ab313646 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Immunohistochemical analysis of paraffin-embedded (A, D) human placenta; (B, E) human glioblastoma; (C, F) human lung adenocarcinoma tissue.
A-C : Sections were incubated with anti-EGFR antibody [SP84] - C-terminal (ab227642; 1 : 100 ) for 30 mins at room temperature. Positive staining on human placenta (image A), glioblastoma (image B), and lung adenocarcinoma (image C). D-F : Sections were incubated with anti-EGFRvIII antibody [EPR28380-83] (ab313646; 1 : 100 [5.09 µg/mL]) for 30 mins at room temperature. Positive staining on human glioblastoma (image E), no staining on placenta (image D) or lung adenocarcinoma (image F). The immunostaining was performed on a Leica Biosystems BOND® RX instrument counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- IP
Supplier Data
Immunoprecipitation - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
EGFRvIII was immunoprecipitated from 0.35 mg of 293T (human embryonic kidney epithelial cell) transfected with a human EGFRvIII expression vector containing a His-tag using ab313646 at 1/30 dilution (2µg in 0.35mg whole cell lysate). Western blot was performed on the immunoprecipitate using ab313646 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/5000 dilution. Isotype control - Rabbit monoclonal IgG (ab172730).
Lanes 1-3 : 293T (human embryonic kidney epithelial cell) transfected with a human EGFRvIII expression vector containing a His-tag
Lane 1 : whole cell lysate at 0.3µg
Lane 2 : IP with ab313646
Lane 3 : IP with Isotype control (ab172730)
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-EGFRvIII antibody [EPR28380-83] (ab313646) at 1/30 dilution
All lanes:
293T (human embryonic kidney epithelial cell) transfected with a human EGFRvIII expression vector containing a His-tag whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Blocking and diluting buffer and concentration : 5% NFDM/TBST This antibody recognizes human EGFRvIII but not human wild-type EGFR. In western blot, anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution, anti-His antibody (ab213204) staining at 1/5000 dilution, and anti-EGFR antibody staining at 1/1000 dilution.
All lanes:
Western blot - Anti-EGFRvIII antibody [EPR28380-83] (ab313646) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) transfected with an empty vector containing a His tag, whole cell lysate at 10 µg
Lane 2:
293T transfected with a human EGFR expression vector containing a His tag, whole cell lysate at 10 µg
Lane 3:
293T transfected with a human EGFRvIII expression vector containing a His tag, whole cell lysate at 10 µg
Lane 4:
293T transfected with a human EGFRvIII expression vector containing a His tag, whole cell lysate at 2.5 µg
Lane 5:
293T transfected with a human EGFRvIII expression vector containing a His tag, whole cell lysate at 0.62 µg
Lane 6:
293T transfected with a human EGFRvIII expression vector containing a His tag, whole cell lysate at 0.31 µg
Lane 7:
293T transfected with a human EGFRvIII expression vector containing a His tag, whole cell lysate at 0.16 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 134 kDa
false
Exposure time: 5.5s
- WB
Supplier Data
Western blot - Anti-EGFRvIII antibody [EPR28380-83] (AB313646)
Blocking and diluting buffer and concentration : 5% NFDM/TBST This antibody does not recognize human wild-type EGFR. (A) : anti-EGFRvIII antibody (ab313646) staining at 1/1000 dilution, (B) : anti-EGFR antibody staining at 1/1000 dilution, (C) : anti-GAPDH antibody [EPR16891] – Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-EGFRvIII antibody [EPR28380-83] (ab313646) at 1/1000 dilution
Lane 1:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
EGFR knockout HeLa whole cell lysate at 20 µg
Lane 4:
Human placenta tissue lysate at 20 µg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lane 4:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 134 kDa
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-EGFRvIII antibody [EPR28380-83] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EGFRvIII modifies signaling pathways that promote cell survival and proliferation. It is a part of cell membrane-based complexes interacting with proteins like PI3K and Src which helps in activating downstream signaling cascades. This constitutive signaling leads to increased oncogenic potential allowing the cells to thrive in uncontrolled manner contributing to tumor progression and resistance to conventional therapies.
Pathways
EGFRvIII participates in key signaling pathways such as the PI3K/AKT pathway and the RAS/RAF/MEK/ERK pathway. These pathways are important in transmitting signals from receptor tyrosine kinases to the cell nucleus. EGFRvIII links with proteins like AKT and ERK to drive processes that control growth and survival. The dysregulation of these pathways due to EGFRvIII activity can result in enhanced proliferative and survival signals in cancer cells.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download enhancedValidationDataWebsite|en
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com